>>7608470

https:// lovinmalta.com/opinion/analysis/what-this-new-17-black-story-means-for-keith-schembri-and-konrad-mizzi/

t turns out that the mysterious Dubai company 17 Black is owned by none other than Yorgen Fenech, the CEO of the powerful Tumas Group, which is one of the business partners in the Electrogas consortium running the LNG power station.

17 Black was one of two Dubai companies which were supposed to transfer monthly fees of €150,000 to the Panama companies of Tourism Minister Konrad Mizzi and OPM chief of staff Keith Schembri.

Fenech opened a bank account in Dubai for 17 Black in June 2015, two months after Enemalta signed multiple contracts binding it to buy €131.6 million worth of LNG from Electrogas yearly for ten years. At the time, Mizzi was Energy Minister, politically responsible for Enemalta.

Fenech’s ownership of 17 Black is the fourth link between Mizzi’s and Schembri’s Panama companies and the LNG power station. Leaked documents from the Financial Intelligence Analysis Unit (FIAU) had already shown how 17 Black had received €161,000 from Mario Pullicino, the local agent for the tanker supplying gas to the LNG power station, and two separate payments amounting to €1.1 million from an Azeri national. The Azerbaijan link is crucial as one of the three shareholders of Electrogas is Socar, the Azeri state-owned energy company.

>>7608532

>>7608262 pb

>Truvian…

At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic. —– At Illumina, their goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, they strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic. —– Illumina's sequencing and array technologies fuel advancements in life science research, translational and consumer genomics, and molecular diagnostics.

music = numbers math in time

the media weaponized to control select extinction

How many brains are being desensitized to the concept of mass selective genetic targeting for commercialized consumption or otherwise extinction

These studies will help make the realization of personalized medicine possible.

personalized medicine possible = [DNA ] Targeted Weaponized Delivered

>>7608405

line to get in Mara Largo